Firms
Theme

CORZ

Core Scientific, Inc. · NASDAQ

News

6 latest

No direct coverage yet · Showing articles that mention CORZ

The Motley Fool

Stock Market Today, Oct. 20: IREN Slides on Funding Worries and Rate Fears

IREN stock fell 4% on October 20, 2026, as premarket funding worries and interest rate concerns pressured the AI cloud and data center operator. While peers like Applied Digital and Core Scientific showed steadier demand, IREN's $7.6 billion debt load and dependence on financing remain key concerns. The company's legacy Bitcoin mining business continues to generate most of its revenue, which could provide some insulation from AI cloud sector headwinds.

The Motley Fool

Stock Market Today, Oct. 19: IREN Rallies on AI Infrastructure Sentiment Rebound

IREN stock rallied 2.74% on October 19, 2026, following a Goldman Sachs upgrade of CoreWeave that lifted sentiment across AI infrastructure stocks. The sector had been battered after a Gartner report predicted 80% of neocloud providers would fail by 2030, but Goldman's upgrade suggested investors were overestimating financial risks and underestimating AI boom returns. IREN shares remain down 27% year-to-date despite the recovery.

Zacks Investment Research

APLD's Interest Costs Surge: Can AI Growth Restore Profitability?

Applied Digital (APLD) is struggling with profitability despite 322% revenue growth to $341.9M in Q1 FY27, as interest expenses surged 866% to $77.4M and the company posted a $221M net loss. With $6.4B in debt and $2.16B in future interest payments, APLD must balance aggressive infrastructure investments with financing costs. Peers CoreWeave and Core Scientific face similar challenges converting strong AI demand into sustainable profitability.

The Motley Fool

Stock Market Today, Oct. 15: Iren Stock Recovers, but Still Slides on Concerns Over Neocloud Provider Viability

Iren (IREN) closed down 0.56% at $30.39 after initially plunging below $27 following Gartner's warning that over 80% of neocloud providers could cease independent operations by 2030 and $3.5 trillion in AI infrastructure investments could be at risk. The stock recovered somewhat as investors recognized Iren has about half its GPU capex funded through customer prepayments, suggesting company-specific resilience versus sector-wide concerns.

Zacks Investment Research

Should Investors Hold or Fold APLD Stock After Its Q1 Earnings Miss?

Applied Digital reported Q1 fiscal 2027 revenues surging 322% to $341.9 million, beating estimates, but posted a wider loss per share of 76 cents, missing expectations. Despite a $36 billion contracted revenue base and improving adjusted EBITDA, the company faces challenges from widening GAAP losses, $6.4 billion in debt, heavy capital requirements, and uncertainty around AI demand. The stock trades at a premium valuation of 7.76X sales versus the industry's 2.48X multiple and has underperformed peers over the past year.

Zacks Investment Research

Can APLD's $36B Contracted Revenue Base Drive Long-Term Growth?

Applied Digital (APLD) has a substantial $36 billion contracted revenue base across 1.41 GW of capacity, with over 600 MW expected online within 12 months. However, the company faces significant financing and construction risks, while competitors Core Scientific and TeraWulf are rapidly narrowing APLD's contracted-revenue lead with $24B and $27B in contracted revenues respectively. APLD carries a Zacks Rank #5 (Strong Sell) rating with a premium valuation and widening projected losses.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $CORZ · 0 threads

Sign in to post on $CORZ

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev